WHO ICTRP trial

Clinical study on Airborne Low Intensity Multi frequency Ultrasound in Type 2…

CTRI/2019/04/018419 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2019/04/018419
Public title Clinical study on Airborne Low Intensity Multi frequency Ultrasound in Type 2 Diabetic Patients
Scientific title A Randomized, multi-center, Double Blind, Interventional, Placebo Controlled Study To Evaluate Efficacy and Safety of ALIMFUS - Airborne Low Intensity Multi frequency Ultrasound, as an Add-on therapy to Oral Hypoglycemic Agent (OHA) in Type II Diabetic Patients - NIL
Primary sponsor Aquatic Remedies Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India
Conditions Health Condition 1: E119- Type 2 diabetes mellitus without complications
Interventions Intervention1: Airborne Low Intensity Multi frequency Ultrasound instrument: Airborne Low Intensity Multi frequency Ultrasound instrument that emits sound energy by using the quartz crystal technology. Frequency range of ALIMFUS is between…
Registration date Apr 4, 2019
Target size 100
Secondary IDs GLUCOSTIM/DM /2019, Version 1.0, 4th Feb 2019
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations